Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Avedro
201 Jones Road
Waltham, MA 02451
Phone: 781-768-3400
http://avedro.com/

Avedro is a privately held medical device and pharmaceutical company advancing the science and technology of corneal crosslinking. The Company\'s products include capital equipment and related pharmaceutical products. The products are currently used to treat several pathologies as well as to improve Lasik procedure outcomes in a procedure known as Lasik Xtra. In 2012 there were almost 50,000 Lasik Xtra procedures performed worldwide with Avedro\'s products. The Company is preparing to launch a new device platform which will open up significant new procedure opportunities that the Company has already demonstrated in early trials. Outside the US, Avedro has obtained CE Mark for its KXL System and its family of riboflavin products. The Company\'s technology is currently being used in three Phase III clinical studies in the US involving over 100 sites. Avedro products are not for sale in the US.

Key Contact
Name
Reza Zadno
Title
CEO
Funding Events

Date
Amount
Type
Investors
Valuation
03/05/13 $43,000,000 Series D Aperture Venture Partners
Borealis Ventures
De Novo Ventures
Echelon Ventures
Flagship Ventures
SCP Vitalife Partners
Third Point Ventures
undisclosed
11/16/15 $32,000,000 InterWest Partners
OrbiMed Advisors
undisclosed
04/27/17 $42,000,000 HealthQuest Capital
InterWest Partners
OrbiMed Advisors
undisclosed
05/02/18 $25,000,000 HealthQuest Capital
InterWest Partners
Lilly Asia Ventures
OrbiMed Advisors
undisclosed


Featured Reading